Hyperpolarized 13C MRS is a powerful emerging technique for assessing metabolic liver diseases, including diabetes and fatty liver. Chemical shift separation allows monitoring of many metabolites at once. Here, we explore the possibility of co-polarizing [1-13C]pyruvate and [2-13C]dihydroxyacetone to simultaneously assess two important metabolic pathways that are altered in liver disease. Co-polarization was successful, with preserved T1 relaxation times. Although co-polarization led to modest decreases in polarization levels, all expected metabolites were observed when injected into a healthy rat. By examining two pathways at the same time, co-polarization can be an important tool for assessing liver disease.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords